Two years in growth hormone 2017-18.

What It Covers

This review looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Two new approaches to diagnosis have been proposed: one involves a classical endocrine test of GH production using a GH secretagogue to test the Ghrelin axis, and shows promise in the diagnosis of adult GH deficiency.

Why It Was Studied

This brief review highlights new studies in three areas of the GH field, namely diagnostics, therapeutics and biomarkers.

The diagnosis of GH deficiency has always presented a challenge: there is no "gold standard" test of GH status, and GH levels during stimulation testing are affected by many factors that limit diagnostic accuracy.

What Was Measured

The diagnosis of GH deficiency has always presented a challenge: there is no "gold standard" test of GH status, and GH levels during stimulation testing are affected by many factors that limit diagnostic accuracy.

The other uses a completely different approach analysing the individual's gene expression profile as a surrogate for GH status with high levels of test accuracy.

Topics PubMed links to this paper include Growth Disorders and Human Growth Hormone.

What This Means in Plain Language

This is a review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 2020 (Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society), a journal based in Scotland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.